Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-02-06FDA Approved: LUNESTA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for LUNESTA (eszopiclone) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2019-02-06FDA Approved: ESTAZOLAM — Supplemental Application (Novitium Pharma LLC)
The FDA approved a supplemental application for ESTAZOLAM (Estazolam) by Novitium Pharma LLC under an ANDA, authorizing changes to the appro…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Melatonin Use for Sleep Problems in Alcohol Dependent Patients [Phase 2]
A completed Phase 2 clinical trial evaluated melatonin for sleep problems in patients with alcohol use disorder.
-
CLINICAL_TRIALS research · 2019-02-01Clinical Trial Update: Self-acupressure for Cancer-related Symptom Cluster of Insomnia, Depression, and Anxiety: a Feasibility Study [NA]
This entry notes a feasibility study evaluating self-acupressure to address the cancer-related symptom cluster of insomnia, depression, and …
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Music for Dementia-related Sleep Problems [NA]
This entry notes the completed status of a clinical trial evaluating music as a sleep aid for dementia-related insomnia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-01-16FDA Approved: ESTAZOLAM — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for ESTAZOLAM (Estazolam) from Actavis Pharma, Inc. for the generic product. The approval confirms t…
-
FDA approval · 2018-12-21FDA Approved: ROZEREM — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ROZEREM (ramelteon) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2018-11-30FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Supplemental Application (Armas Pharmaceuticals Inc.)
FDA approved a supplemental application for diphenhydramine hydrochloride from Armas Pharmaceuticals Inc.
-
FDA approval · 2018-11-23FDA Approved: TEMAZEPAM — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's Original Application for Temazepam, a generic benzodiazepine hypnotic used for short-term tre…
-
FDA approval · 2018-11-07FDA Approved: LUNESTA — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for LUNESTA (eszopiclone) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2018-10-24FDA Approved: EDLUAR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Edluar (zolpidem tartrate) submitted by Viatris Specialty LLC.
-
FDA approval · 2018-10-23FDA Approved: NAPROXEN SODIUM PM — Original Application (Strategic Sourcing Services LLC)
FDA approved Naproxen Sodium PM, a combination of naproxen sodium and diphenhydramine, under an Original Application by Strategic Sourcing S…
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Comparison of Quetiapine and Trazodone Treatment for Insomnia in Dually Diagnosed Veterans [Phase 4]
Phase 4 trial comparing quetiapine to trazodone for insomnia in veterans with dual diagnoses was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Management of Insomnia in Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update on managing insomnia in breast cancer patients; results posted after completion.
-
FDA approval · 2018-09-14FDA Approved: AMBIEN — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Ambien (zolpidem tartrate) by Cosette Pharmaceuticals, Inc. The approval concerns a modification…
-
FDA label_change · 2018-09-14FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for zolpidem tartrate by Sanofi-Aventis U.S. LLC to update the labeling of the approved insomnia med…
-
FDA approval · 2018-08-22FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Original Application (Armas Pharmaceuticals Inc.)
FDA approved the original generic application for diphenhydramine hydrochloride from Armas Pharmaceuticals, making a generic diphenhydramine…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Sleep Therapy for Insomnia and Depression [NA]
A University of Michigan sponsor completed a clinical trial evaluating sleep therapy for individuals with co-occurring insomnia and depressi…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Treatment for Insomnia During Pregnancy [NA]
A completed clinical trial update on treatment for insomnia during pregnancy. The study was sponsored by Stanford University.
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Targeting Sleep in Kids With Autism Spectrum Disorder [NA]
The clinical trial investigating sleep interventions for children with autism spectrum disorder has completed.
-
CLINICAL_TRIALS research · 2018-07-18Clinical Trial Update: Relationship of Nocturnal Concentrations of Melatonin, γ-aminobutyric Acid and Total Antioxidants With Insomnia
A clinical trial update, sponsored by the China Rehabilitation Research Center, examining whether nocturnal concentrations of melatonin, GAB…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Controlled Study of Chain Blanket for Insomnia [NA]
The clinical trial update indicates that the controlled study of Chain Blanket for insomnia has completed.
-
FDA approval · 2018-07-12FDA Approved: BELSOMRA — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for BELSOMRA (suvorexant) from Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Reducing Suicidal Ideation Through Insomnia Treatment [Phase 4]
Phase 4 clinical trial update examining whether treating insomnia reduces suicidal ideation in people with insomnia and depression; results …
-
CLINICAL_TRIALS research · 2018-06-18Clinical Trial Update: The Effects of MBSR on Patients With TBI and Chronic Insomnia [NA]
This entry notes an ongoing clinical trial examining the effects of Mindfulness-Based Stress Reduction on patients with chronic insomnia and…